Medical Oncology and Hematology 2012:

Transcription

1 Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes October 18 20, 2012 The University of Texas MD Anderson Cancer Center R. Lee Clark Clinic Floor 11, Hickey Auditorium 1515 Holcombe Boulevard Houston, Texas

2 Goal The goal of this program will be to address the ongoing need for education of practicing physicians with new cancer therapy and updating treatment guidelines and focus on new advances within the last year and other groundbreaking scientific discoveries. At the conclusion of the conference, physicians and other healthcare providers will have a new awareness and knowledge in optimal use of new therapies for cancer. Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes October 18 20, 2012 The University of Texas MD Anderson Cancer Center R. Lee Clark Clinic, Floor 11 Hickey Auditorium, 1515 Holcombe Boulevard, Houston, Texas Educational Objectives After attending the conference, participants should be able to Incorporate new knowledge for each cancer diagnosis to articulate optimal treatments guided by prognostic factors and treatment options (Knowledge, Competence, Performance, and Patient Outcomes). Utilize available clinical trials for promising new treatments and appropriately select candidates for referral (Knowledge, Competence, Performance, and Patient Outcomes). Apply principles of personalized cancer treatment for each diagnosis (Knowledge, Competence, Performance, and Patient Outcomes). Implement new knowledge of cancer genetics to improve treatment of cancer patients (Knowledge, Competence, Performance, and Patient Outcomes). Target Audience This conference will be beneficial to primary care physicians, medical oncologists and hematologists, trainees, fellows, and other healthcare professionals. Program Chair Hagop M. Kantarjian, MD Program Co-Chairs Raymond N. DuBois, MD, PhD Richard E. Champlin, MD Lyle D. Green, MBA Organizing Committee Yvonne S. Bazunu Doreen Brandenberger Elnar Koseoglu Tina Nelson, CMP

3 Educational Method Lectures/Didactic Question and Answer Session Conference Post-Evaluation Evaluation A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. Accreditation/Credit Designation The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME Certificates and Attendance Verification Certificates Certificates awarding AMA PRA Category 1 Credit TM or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations. on Twitter Get real-time conference updates and join the discussion with The #MOHC2012 hashtag. Join us for a joint reception/tweetup at 5:30 p.m. on Friday, October 19, :00 pm Registration Program Thursday, October 18, :00 Welcome and Opening Remarks Raymond N. DuBois, MD, PhD PLENARY SESSIONS 3:15 Overview of Clinical Trials Aman U. Buzdar, MD 4:00 Translating the Cancer Genome Lynda Chin, MD 4:45 Closing Remarks/Preview of Day Two Peter C. Hu, PhD

4 What s New in Solid Tumors? THORACIC/HEAD & NECK SESSION 8:40 The Importance of Molecular Diagnostics and Therapy in Lung Cancer George R. Blumenschein, Jr., MD 9:00 Latest Treatments of Head and Neck Cancer Merrill S. Kies, MD 9:20 Ask the Experts 9:35 Break Friday, October 19, :00 am Registration and Continental Breakfast 8:00 Welcome and Opening Remarks Ronald A. DePinho, MD 8:10 KEYNOTE SPEAKER Healthcare Reform - Impact on Cancer Care Thomas W. Burke, MD GENITOURINARY SESSION 9:45 Targeted Therapies in Renal Cell Cancer Nizar M. Tannir, MD 10:05 Prostate Cancer Overview Christopher J. Logothetis, MD 10:25 Testicular Cancer/Germ Cell Tumors Lance C. Pagliaro, MD 10:45 Ask the Experts BRAIN SESSION 11:00 State-of-the-Art Approach to Brain Tumor Therapy W.K. Alfred Yung, MD 11:20 Ask the Expert

5 MELANOMA SESSION 2:25 The Immunotherapy of Melanoma Patrick Hwu, MD 2:40 Targeted Therapy of Melanoma Michael A. Davies, MD, PhD 2:55 Ask the Experts SARCOMA SESSION 3:10 Overview of Sarcoma Therapy Vinod Ravi, MD 3:30 Ask the Expert 3:45 Break PERSONALIZED THERAPY SESSION 11:35 Delivering Personalized Therapy in Solid Tumors Apostolia M. Tsimberidou, MD, PhD 11:55 Ask the Expert GYNECOLOGICAL SESSION 12:00 pm Lunch (provided) Treatment of Gynecological Cancers Karen H. Lu, MD 12:35 Ask the Expert BREAST SESSION 4:00 Treatment of Early Stage Breast Cancer Vicente Valero, MD 4:20 Treatment of Late Stage Breast Cancer Ricardo Hugo Alvarez, MD 4:40 Novel Strategies for Inflammatory Breast Cancer Naoto T. Ueno, MD, PhD 5:00 Ask the Experts 5:15 Adjourn 5:30 Bienvenido a la Recepción - Please Join Us (Come visit with Colleagues) GASTROINTESTINAL SESSION 1:00 Esophageal and Gastric Cancer Jaffer A. Ajani, MD 1:30 New Developments in Colorectal Cancer Treatment Arvind Dasari, MBBS 1:50 Pancreas and NET James C. Yao, MD 2:10 Ask the Experts

6 Saturday, October 20, :00 am Registration and Continental Breakfast 8:00 Welcome and Opening Remarks Elizabeth Shpall, MD What s New in Hematology? HEMATOLOGY SESSION 8:10 State-of-the-Art Treatment of Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia Stefan H. Faderl, MD 8:30 Treatment of Chronic Myelogenous Leukemia Jorge E. Cortes, MD 8:50 Treatment of Chronic Lymphocytic Leukemia William G. Wierda, MD, PhD 9:10 Treatment of Myelodysplastic Syndrome Guillermo Garcia-Manero, MD 9:30 Ask the Experts 9:45 Break 10:00 Aggressive Lymphomas Luis E. Fayad, MD 10:20 Indolent Lymphomas Fredrick B. Hagemeister, MD 10:40 Hodgkin s Disease Anas Younes, MD 11:00 Myeloma Jatin Shah, MD 11:20 Ask the Experts 11:35 Novel Strategies in Stem Cell Transplantation Elizabeth Shpall, MD 12:00 pm Closing Remarks and Adjourn MD ANDERSON FACULTY Ronald A. DePinho, MD, President Thomas W. Burke, MD, Executive Vice President and Physician-In-Chief Raymond N. DuBois, MD, PhD Provost and Executive Vice President Jaffer A. Ajani, MD Gastrointestinal Medical Oncology Ricardo Hugo Alvarez, MD Assistant Breast Medical Oncology George R. Blumenschein, Jr., MD Associate Thoracic/Head & Neck Medical Oncology Aman U. Buzdar, MD, Breast Medical Oncology Richard E. Champlin, MD and Chair Stem Cell Transplantation and Cellular Therapy Lynda Chin, MD and Chair Genomic Medicine Jorge E. Cortes, MD, Leukemia Arvind Dasari, MBBS Assistant Gastrointestinal Medical Oncology Michael A. Davies, MD, PhD Assistant Melanoma Medical Oncology Stefan H. Faderl, MD, Leukemia Luis E. Fayad, MD Associate Lymphoma/Myeloma Guillermo Garcia-Manero, MD, Leukemia Fredrick B. Hagemeister, MD Lymphoma/Myeloma Peter C. Hu, PhD Associate School of Health Professions Patrick Hwu, MD and Chair Melanoma Medical Oncology Hagop M. Kantarjian, MD and Chair Leukemia Merrill S. Kies, MD Thoracic/Head and Neck Medical Oncology Christopher J. Logothetis, MD and Chair Genitourinary Medical Oncology Karen H. Lu, MD Gynecologic Oncology Lance C. Pagliaro, MD Associate Genitourinary Medical Oncology Vinod Ravi, MD Assistant Sarcoma Medical Oncology Jatin Shah, MD Assistant Lymphoma/Myeloma Elizabeth Shpall, MD Stem Cell Transplantation Nizar M. Tannir, MD Associate Genitourinary Medical Oncology Apostolia M. Tsimberidou, MD, PhD Associate Investigational Cancer Therapeutics Naoto T. Ueno, MD, PhD Breast Medical Oncology Vicente Valero, MD Breast Medical Oncology William G. Wierda, MD, PhD Associate Leukemia James C. Yao, MD Associate Gastrointestinal Medical Oncology Anas Younes, MD Lymphoma/Myeloma W.K. Alfred Yung, MD and Chair Neuro-Oncology

7 Registration Information On-site registration will open at 2:00 p.m. on Thursday, October 18, The opening session of the conference will begin at 3:00 p.m. on Thursday, October 18, 2012 and the conference will adjourn on Saturday, October 20, Advance registration is encouraged as space and materials are limited. Please see registration form for applicable fees. The deadline for advance registration is October 8, There are three ways to register: Mail to: CME/Conference Management Unit 1381, The University of Texas MD Anderson Cancer Center, P.O. Box , Houston, TX Fax to: On-line at We accept the following forms of payment: Check (payable through U.S. banks only) Money Order Credit Cards (MasterCard, VISA, and American Express) Cash (on-site registration only) A receipt and confirmation letter will be sent to you within ten working days of receipt of your fee. The full conference registration fee includes the tuition, syllabus, continental breakfasts, breaks, lunch, and welcome reception. Refund/Cancellation Policy: The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before October 8, No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, , or the contact numbers as given on the registration form. In case of activity cancellation, liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee. The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. For additional information, contact CME/Conference Management at or toll free at Special Assistance Contact the Department of CME/Conference Management at or toll free at if you have any special dietary or ADA accommodation needs. Accommodations A block of rooms has been reserved for conference attendees at the Houston Marriott at the Texas Medical Center, located at 6580 Fannin Street, Houston, Texas Early hotel reservation is suggested. The hotel phone number is When you make reservations be sure to mention the Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes Conference to be assured of receiving the special meeting rate of $ single or double occupancy. Please add 17% (Texas) state and local taxes. Reservations and deposits received after October 8, 2012 will be confirmed if space is available and at current hotel published guest room rates. Air Travel MD Anderson has a program with United Airlines for discounted air travel. For discounts, call your travel professional or United s MeetingWorks toll free at Outside of the United States, please call your local United Airlines Reservation Office. Mention Z Code: ZM6M and Agreement Code: Ground Transportation (prices are subject to change and variable depending on location of conference) Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU). Taxicabs are available at an estimated cost of $50-$60 to or from William P. Hobby Airport or George Bush Intercontinental Airport. SuperShuttle operates a shuttle bus between George Bush Intercontinental Airport and the Houston Marriott at the Texas Medical Center for $27 one-way and $54 roundtrip. For more information, call or toll free at , or online at SuperShuttle operates a shuttle bus between William P. Hobby Airport and the Houston Marriott at the Texas Medical Center for $24 one-way and $48 round-trip. For more information, call or toll-free at , or online at Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or CME/Conference Management. All responses will be forwarded to the Program Chair for consideration. The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity. Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth. Photographing, audio taping and videotaping are prohibited.

8 Please Join Us Dr. Ronald A. DePinho President, The University of Texas MD Anderson Cancer Center and Dr. Hagop M. Kantarjian THIS IS NOT A SELF-MAILER-Address to: Medical Oncology and Hematology 2012 Department of CME/Conference Management Unit 1381 The University of Texas MD Anderson Cancer Center PO Box , Houston, TX or fax to Make check or money order payable to: The University of Texas MD Anderson Cancer Center REGISTRATION FEES Physicians/Scientists 1 Postmarked before 10/8/12...$ Postmarked after 10/8/12...$ MD Anderson Faculty/ Alumni 1 Postmarked before 10/8/12...$ Postmarked after 10/8/12...$ Fellows/Students/Residents 1 Postmarked before 10/8/12...$ MD Anderson Staff, Trainees & Allied Health Professionals 1 Postmarked before 10/8/12...$ Healthcare Professionals 1 Postmarked before 10/8/12...$ Postmarked after 10/8/12...$ Conference Chair, and Chair, Leukemia Cordially invite you to attend a reception Friday, October 19, :30 7:00 p.m. The University of Texas MD Anderson Cancer Center Hickey Auditorium Foyer Main Building, Floor Holcombe Blvd., Houston, Texas This reception is being held in conjunction with themedical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes Conference uuu CONFERENCE REGISTRATION Medical Oncology and Hematology 2012: Clinical and Scientific Approaches that Enhance Patient Outcomes October 18 20, 2012 Last Name First MI Highest Degree Department (include box no.) Specialty Institution Physician oyes ono Street City State/Foreign Country/Zip or Mail Code Daytime Phone (with area code) Cell Phone (with area code) Fax (with area code) Address Emergency Contact Phone (with area code) Charge the following: ovisa omastercard oamerican Express Credit Card Holder Name (First/Last) Credit Card Holder Billing Address & ZIP Code Credit Card Number or MD Anderson Interdepartmental Transfer (IDT) No. Expiration Date Authorized Signature REQUIRED for credit card or IDT MD Anderson Employee ID No. (REQUIRED) IDT Approver Name (First/Last) please print IDT Approver Hosted by the Office of Physician Relations

9 The University of Texas MD Anderson Cancer Center CME/Conference Management - Unit / PO Box Houston, Texas Non-Profit Org. U.S. Postage P A I D Houston, TX Permit No. 7052